TRDA compared with INCY: revenue, margins and what each company keeps, and the suppliers and customers both name

TRDAEntrada Therapeutics, Inc.

Mkt capRevenueRevenue

INCYIncyte Corp

Mkt capRevenueRevenue

Compare

TRDAEntrada Therapeutics, Inc.

INCYIncyte Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

TRDA

1 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▼−10.08%—

Q2 FY26±56.7%▼−2.49%×0.04

May 7 '26±24.3%▼−57.27%×2.36

Q1 FY26±38.0%▲+6.76%×0.18

INCY

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±7.5%▼−0.06%×0.01

Q2 FY26±7.4%▲+9.30%×1.26

= impliedTRDA realized, solidINCY realized, hatchedOne scale, both sides: full bar = 58%× = |realized| ÷ impliedSource: market data

Q1 FY26

±6.9%

▲+2.12%

×0.30

Feb 10 '26±6.2%▼−8.24%×1.32

TRDAEntrada Therapeutics, Inc.

4.86▲+6.91%· post 4.87

Mkt cap$191.4MRevenue$905,000Q3 FY26Revenue$25MFY25

INCYIncyte Corp

119.70▲+1.43%· post 119.55

ClosedNov 6 '26

Mkt cap$24.4BRevenue$1.6BQ3 FY26Revenue$5.1BFY25

Compare

ClosedNov 6 '26

TRDAEntrada Therapeutics, Inc.

INCYIncyte Corp

4.86▲+6.91%post 4.87

Price

119.70▲+1.43%post 119.55

$191.4M

Mkt cap

$24.4B

Q3 FY26$905,000

Revenue

$1.6BQ3 FY26

FY25$25M

Revenue

$5.1BFY25

TRDA4.86▲+6.91%vsINCY119.70▲+1.43%ClosedNov 6 '26